MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 159 filers reported holding MERSANA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $242,700 | -80.1% | 59,051 | -71.7% | 0.00% | -85.7% |
| Q4 2022 | $1,221,417 | -30.2% | 208,433 | -19.4% | 0.01% | -36.4% |
| Q3 2022 | $1,749,000 | +8.4% | 258,687 | +326.8% | 0.01% | +10.0% |
| Q4 2020 | $1,613,000 | -38.6% | 60,615 | -57.0% | 0.01% | -41.2% |
| Q3 2020 | $2,626,000 | -30.1% | 141,024 | -12.2% | 0.02% | -37.0% |
| Q2 2020 | $3,759,000 | – | 160,635 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |